S.O. (E): - In exercise of powers conferred by Section 3 of FT (D&R) Act, 1992, read with paragraph 1.02 and 2.01 of the Foreign Trade Policy, 2015-2020, as amended from time to time, the Central Government hereby inserts Import Policy for Human Biological Samples for commercial purposes under General Notes 17 to Schedule – 1 (Import Policy) and Export Policy for Human Biological Samples for commercial purposes under General Notes 4 to Schedule – 2 (Export Policy) of ITC (HS), 2012 as under:

“The import of human biological samples by the Indian diagnostic laboratories / Indian Clinical Research Centres for lab analysis / R & D testing or export of these materials to foreign laboratories should be permitted by Customs authorities at the port of entry / exit without prior approvals (import licence / export permit) from any other Government agency, provided the concerned Indian company / agency submits an undertaking that they are following and will follow all the applicable rules, regulations & procedures for safe transfer and disposal of the biological samples being imported / exported as per the related norms / regulations set by WHO* / DGFT** [SCOMET items in Export Policy of ITC (HS), 2012, Schedule – 2 (Export Policy)] / Ministry of Environment, Forests and Climate Change***, Government of India, to the Customs authorities at the port of entry / exit along with the details of such samples”.

2. Effect of this Notification: Policy condition for import /export of human biological samples for commercial purposes is laid down.

* (i) http://apps.who.int/iris/bitstream/10665/149288/1/WHO_HSE_GCR_2015.2_eng.pdf?ua=1)

(ii) http://www.who.int/csr/resources/publications/biosafety/en/Biosafety7.pdf

** http://dgft.gov.in/exim/2000/scomet/scomet2011.pdf

*** (i) http://envfor.nic.in/legis/env/env1.html

(ii)http://envfor.nic.in/legis/hsm/hsm3.html
 

(Anup Wadhawan)
Director General of Foreign Trade
E-mail: dgft[at]nic[dot]in

[Issued from F.No.01/89/180/Misc.82/AM-05/PC-2 (A)]